
Cafage-CL 50mg/31.25mg Dry Syrup
Marketer
Allenge India
Salt Composition
Cefpodoxime Proxetil (50mg) + Clavulanic Acid (31.25mg)
Overview Cafage-CL 50mg/31.25mg Dry Syrup
Cafage-CL 50mg/31.25mg oral suspension is a powerful combination antibiotic, effective against various serious bacterial infections affecting children. Its dual active components combat infections in the ears, throat, lungs, skin, and urinary tract by hindering bacterial growth. Administer this medication one hour before or two hours after your child's meals; if stomach upset occurs, give it with food. Strictly adhere to the prescribed dosage, tailored to your child's age, weight, and the specific infection's severity. If your child vomits the medicine within 30 minutes, repeat the dose; however, avoid doubling the dose if it's near the next scheduled time. Minor, transient side effects like vomiting, diarrhea, nausea, rash, or headache may occur, typically resolving as your child's body adjusts. Persistent or concerning side effects warrant immediate medical consultation. Thoroughly inform your pediatrician of your child's complete medical history, including allergies, heart conditions, blood disorders, birth defects, respiratory issues, lung abnormalities, digestive problems, skin conditions, liver problems, and kidney dysfunction. This comprehensive information is vital for accurate dosage and treatment planning.
Primary Ingredients of Cafage-CL 50mg/31.25mg Dry Syrup
No information provided. Unable to rewrite.
Uses of Cafage-CL 50mg/31.25mg Dry Syrup
Managing respiratory illness
Major Benefits of Cafage-CL 50mg/31.25mg Dry Syrup:
Administer this medication precisely as your physician prescribes, adhering to both dosage and treatment length. Always consult the product label for usage instructions prior to consumption. Dissolve the powder completely in sterile water. Ensure thorough mixing before use. Cafage-CL 50mg/31.25mg Dry Syrup can be ingested with or without food; however, consistent timing is recommended.
Common Side effects of Cafage-CL 50mg/31.25mg Dry Syrup:
- Nausea
- Diarrhea
- Headache
- Rash
- Abdominal pain
- Vaginal infection
- Fungal infection of vagina
How to use Cafage-CL 50mg/31.25mg Dry Syrup:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Consult the product label for complete instructions prior to consumption. Dissolve the powder completely in sterile water; shake thoroughly before use. Cafage-CL 50mg/31.25mg Dry Syrup can be ingested with or without food, although consistent timing is recommended.
How Cafage-CL 50mg/31.25mg Dry Syrup works:
Cafage-CL 50mg/31.25mg oral suspension unites Cefpodoxime Proxetil, a bacterial growth inhibitor, with Clavulanic Acid, a beta-lactamase inhibitor. Cefpodoxime Proxetil's mechanism involves disrupting bacterial cell wall synthesis, hindering their ability to thrive. The Clavulanic Acid component counters bacterial resistance mechanisms, optimizing Cefpodoxime Proxetil's antimicrobial effect.
SAFETY ADVICE
KidneySAFE IF PRESCRIBED
Cafage-CL 50mg/31.25mg Dry Syrup presents minimal risk for individuals with kidney impairment; routine dosage alteration isn't typically necessary. Nevertheless, children exhibiting severe kidney dysfunction may need adjusted dosages. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Cafage-CL 50mg/31.25mg Dry Syrup poses no safety concerns for individuals with liver disease and requires no dosage modification. Nevertheless, parental consultation with a pediatrician is advised prior to administering Cafage-CL 50mg/31.25mg Dry Syrup to children exhibiting severe hepatic impairment.
What if you forget to take Cafage-CL 50mg/31.25mg Dry Syrup :
Remain calm. Unless otherwise directed by your pediatrician, administer the missed dose immediately upon recollection. However, omit the missed dose if the next scheduled dose is imminent. Adhere to the prescribed medication schedule; avoid doubling the dose to compensate.
Facts to Know About Cafage-CL 50mg/31.25mg Dry Syrup
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
